Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna stock falls as orders for COVID shots slump
10:44am, Thursday, 23'rd Feb 2023
Moderna Therapeutics Inc (NASDAQ:MRNA) stock started Thursday sharply lower as the COVID vaccine maker reported earnings that fell short of market expectations. As demand for COVID shots has dropped t
Moderna (MRNA) Lags Q4 Earnings and Revenue Estimates
09:47am, Thursday, 23'rd Feb 2023
Moderna (MRNA) delivered earnings and revenue surprises of -22.53% and 0.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Moderna Skids After 2023 Guidance Misses By More Than $2 Billion
08:57am, Thursday, 23'rd Feb 2023
Moderna stock fell early Thursday after guidance for 2023 sales missed forecasts following a mixed fourth-quarter report. The post Moderna Skids After 2023 Guidance Misses By More Than $2 Billion appe
Moderna misses on earnings as costs rise from surplus production capacity, lower demand for Covid shots
08:10am, Thursday, 23'rd Feb 2023
Moderna reported quarterly earnings of $3.61 per share, a 68% decrease from the same period in 2021 when it booked $11.29 per share.
Moderna's Earnings, Revenue Fall on Fewer Vaccine Sales
07:40am, Thursday, 23'rd Feb 2023
Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales.
Moderna and Merck receive FDA breakthrough status for personalized cancer vaccine
07:33am, Thursday, 23'rd Feb 2023
CNBC's Meg Tirrell reports on news from Moderna and Merck.
Moderna Earnings Hit by Falling Covid Vaccine Sales. Stock Slides.
07:33am, Thursday, 23'rd Feb 2023
Shares of the biotech company fell early Thursday, wiping out gains from positive news around its cancer vaccine candidate, as fourth-quarter earnings missed expectations.
Moderna Inc. MRNA, -1.20% said Thursday it had net income of $1.465 billion, or $3.61 a share, in the fourth quarter, down from $4.868 billion, or $11.29 a share, in the year-earlier period. Revenue f
Moderna Pops After FDA Grants Its Cancer Vaccine A Breakthrough Designation
05:29pm, Wednesday, 22'nd Feb 2023
Moderna stock jumped late Wednesday after the FDA granted its Merck-partnered cancer vaccine a breakthrough designation. The post Moderna Pops After FDA Grants Its Cancer Vaccine A Breakthrough Design
Moderna, Merck receives FDA breakthrough status for personalized cancer vaccine
04:46pm, Wednesday, 22'nd Feb 2023
CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on Merck and Moderna receiving FDA breakthrough status for a personalized cancer vaccine.
Moderna stock pops after receiving cancer-vaccine candidate gets FDA breakthrough designation
04:21pm, Wednesday, 22'nd Feb 2023
Moderna Inc. MRNA, -1.20% and Merck Inc. MRK, +0.08% shares increased in after-hours trading Wednesday after the pharmaceutical companies announced that a cancer-vaccine candidate received the “brea
Moderna co-founder talks COVID-19 vaccines, mRNA growth, agriculture portfolio
02:55pm, Wednesday, 22'nd Feb 2023
Moderna Co-Founder and Flagship Pioneering CEO Noubar Afeyan joins Yahoo Finance Live's Anjalee Khemlani and Rachelle Akuffo to discuss building on mRNA technology, the future of vaccines, keeping COV
9 Stocks Jumped 200% In 3 Years Since Covid Rocked The World
08:00am, Wednesday, 22'nd Feb 2023
It's been three years since the Covid crash tanked the S&P 500. But there's been still plenty of ways to make money since.
Moderna to collaborate with Life Edit on gene editing therapies
07:16am, Wednesday, 22'nd Feb 2023
Moderna Inc. MRNA, -3.91% announced Wednesday a collaboration agreement with privately held Life Edit Therapeutics Inc. to discover and develop in vivo gene editing therapies. Moderna's stock edged up
Where Will Moderna Be in 5 Years?
02:00pm, Tuesday, 21'st Feb 2023
Moderna shares have what it takes to gain over time.
